Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Portfolio of clinical research in adult cardiovascular disease as reflected in ClinicalTrials.gov.

Alexander KP, Kong DF, Starr AZ, Kramer J, Chiswell K, Tasneem A, Califf RM.

J Am Heart Assoc. 2013 Sep 26;2(5):e000009. doi: 10.1161/JAHA.113.000009.

2.

Using ClinicalTrials.gov to understand the state of clinical research in pulmonary, critical care, and sleep medicine.

Todd JL, White KR, Chiswell K, Tasneem A, Palmer SM.

Ann Am Thorac Soc. 2013 Oct;10(5):411-7. doi: 10.1513/AnnalsATS.201305-111OC.

3.

Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.

Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A.

JAMA. 2012 May 2;307(17):1838-47. doi: 10.1001/jama.2012.3424.

PMID:
22550198
4.

Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.

Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM.

PLoS Med. 2009 Sep;6(9):e1000144. doi: 10.1371/journal.pmed.1000144. Epub 2009 Sep 8.

5.

The fate of prospective spine studies registered on www.ClinicalTrials.gov.

Ohnmeiss DD.

Spine J. 2015 Mar 1;15(3):487-91. doi: 10.1016/j.spinee.2014.10.008. Epub 2014 Oct 12.

PMID:
25315132
6.

Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.

Subherwal S, Patel MR, Chiswell K, Tidemann-Miller BA, Jones WS, Conte MS, White CJ, Bhatt DL, Laird JR, Hiatt WR, Tasneem A, Califf RM.

Circulation. 2014 Nov 11;130(20):1812-9. doi: 10.1161/CIRCULATIONAHA.114.011021. Epub 2014 Sep 19.

7.

Outcome reporting among drug trials registered in ClinicalTrials.gov.

Bourgeois FT, Murthy S, Mandl KD.

Ann Intern Med. 2010 Aug 3;153(3):158-66. doi: 10.7326/0003-4819-153-3-201008030-00006.

8.

Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.

9.

Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.

Korczak D, Dietl M, Steinhauser G.

GMS Health Technol Assess. 2011 Apr 1;7:Doc02. doi: 10.3205/hta000093.

10.

The state of infectious diseases clinical trials: a systematic review of ClinicalTrials.gov.

Goswami ND, Pfeiffer CD, Horton JR, Chiswell K, Tasneem A, Tsalik EL.

PLoS One. 2013 Oct 16;8(10):e77086. doi: 10.1371/journal.pone.0077086. eCollection 2013. Review.

11.

An analysis of registered clinical trials in otolaryngology from 2007 to 2010: ClinicalTrials.gov.

Witsell DL, Schulz KA, Lee WT, Chiswell K.

Otolaryngol Head Neck Surg. 2013 Nov;149(5):692-9. doi: 10.1177/0194599813506545. Epub 2013 Oct 9.

12.

The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov.

Scoggins JF, Patrick DL.

Contemp Clin Trials. 2009 Jul;30(4):289-92. doi: 10.1016/j.cct.2009.02.005. Epub 2009 Mar 9.

13.

Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry.

Pasquali SK, Lam WK, Chiswell K, Kemper AR, Li JS.

Pediatrics. 2012 Nov;130(5):e1269-77. doi: 10.1542/peds.2011-3565. Epub 2012 Oct 1.

14.

Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007-2013).

Vodicka E, Kim K, Devine EB, Gnanasakthy A, Scoggins JF, Patrick DL.

Contemp Clin Trials. 2015 Jul;43:1-9. doi: 10.1016/j.cct.2015.04.004. Epub 2015 Apr 18.

PMID:
25896116
15.

Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry.

Bernardez-Pereira S, Lopes RD, Carrion MJ, Santucci EV, Soares RM, de Oliveira Abreu M, Laranjeira LN, Ikeoka DT, Zazula AD, Moreira FR, Cavalcanti AB, Mesquita ET, Peterson ED, Califf RM, Berwanger O; Methodological Evaluation of clinical TriAls Study Group.

Am Heart J. 2014 Aug;168(2):213-9.e1. doi: 10.1016/j.ahj.2014.04.013. Epub 2014 May 2.

PMID:
25066561
16.

A comparison of interventional clinical trials in rare versus non-rare diseases: an analysis of ClinicalTrials.gov.

Bell SA, Tudur Smith C.

Orphanet J Rare Dis. 2014 Nov 26;9:170. doi: 10.1186/s13023-014-0170-0.

17.

The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty.

Tasneem A, Aberle L, Ananth H, Chakraborty S, Chiswell K, McCourt BJ, Pietrobon R.

PLoS One. 2012;7(3):e33677. doi: 10.1371/journal.pone.0033677. Epub 2012 Mar 16.

18.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

19.

The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov.

Inrig JK, Califf RM, Tasneem A, Vegunta RK, Molina C, Stanifer JW, Chiswell K, Patel UD.

Am J Kidney Dis. 2014 May;63(5):771-80. doi: 10.1053/j.ajkd.2013.10.043. Epub 2013 Dec 6. Review.

20.

Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.

Cooper K, Chatters R, Kaltenthaler E, Wong R.

Health Technol Assess. 2015 Jul;19(56):1-130. doi: 10.3310/hta19560. Review.

Supplemental Content

Support Center